Risk and Healthcare Costs of Chemotherapy-Induced Neutropenic Complications in Women with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1421-9794|58|1|8-18

ISSN： 0009-3157

Source： Chemotherapy, Vol.58, Iss.1, 2012-02, pp. : 8-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin plus Gemcitabine Chemotherapy in Taxane/Anthracycline-Resistant Metastatic Breast Cancer

By  

Chemotherapy, Vol. 55, Iss. 3, 2009-04 ,pp. : 155-160

Karger

Access to resources Recommend Favorite

The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 217-222

Karger

Access to resources Recommend Favorite

Gemcitabine and Capecitabine Combination Chemotherapy in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and/or Taxanes

By  

Chemotherapy, Vol. 61, Iss. 4, 2016-02 ,pp. : 171-178

Karger

Access to resources Recommend Favorite

Chemotherapy‐Induced Diarrhoea

By  

The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 5, 2000-10 ,pp. : 229-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Associations of Breast Cancer Risk Factors with Premenopausal Sex Hormones in Women with Very Low Breast Cancer Risk

By Houghton Lauren C.   Ganmaa Davaasambuu   Rosenberg Philip S.   Davaalkham Dambadarjaa   Stanczyk Frank Z.   Hoover Robert N.   Troisi Rebecca  

International Journal of Environmental Research and Public Health, Vol. 13, Iss. 11, 2016-10 ,pp. : 1066-1066

MDPI

Access to resources Recommend Favorite